Surveillance Epidemiology and End Results (SEER)

The Surveillance, Epidemiology, and End Results (SEER) Program is a comprehensive National Cancer Institute (NCI) contract vehicle designed to support population-based cancer research, surveillance, and data collection. The primary objective is to gather, analyze, and publish comprehensive cancer incidence, treatment, and survival data from diverse population-based cancer registries across the United States. Through this multiple-award indefinite delivery/indefinite quantity (IDIQ) contract, the NCI aims to create a robust national cancer surveillance system that tracks changes in cancer epidemiology, provides critical insights into cancer patterns, and supports public health research and policy development.

The SEER Program's task orders predominantly involve core infrastructure support, research studies, and specialized cancer data collection efforts, with contract values ranging from approximately $50,000 to over $49 million. Prime contractors are primarily academic medical centers, research universities, and state public health departments, including the University of California San Francisco, Fred Hutchinson Cancer Research Center, University of Kentucky, University of Hawaii, and Louisiana State University Health Sciences Center. Most task orders are cost-sharing or cost-no-fee contracts without specific small business set-aside designations, and they typically have performance periods spanning multiple years, often running through April 2028. The places of performance are distributed across multiple states, with contractors collecting and analyzing cancer data from their respective geographic regions. Key research focus areas include pediatric cancer whole slide imaging, patterns of care studies for specific cancer types, and comprehensive cancer registry infrastructure development.